EBV LMP2A 抗体
-
- 抗原 See all EBV LMP2A products
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
- 适用
- Epstein-Barr Virus (EBV)
-
宿主
- 大鼠
-
克隆类型
- 单克隆
-
标记
- This EBV LMP2A antibody is un-conjugated
-
应用范围
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
- 产品特性
- Purified IgG
- 纯化方法
- Purified
- 免疫原
- Bacterial TrpE-LMP2A fusion protein
- 克隆位点
- 15F9
- 亚型
- IgG1
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.0 mg/mL
-
-
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
: "Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22." in: Neoplasia (New York, N.Y.), Vol. 11, Issue 11, pp. 1174-84, (2009) (PubMed).
: "
-
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
-
- 抗原
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
- 别名
- EPSTEIN-BARR VIRUS LMP2A (EBV LMP2A 产品)
- 别名
- - antibody, LMP2A antibody
- 物质类
- Viral Protein
- 背景
- Synonyms: EBV
-